Hydrochloric Acid → HCID 86695407, compound

HRID 1520452Notes

Reaction equation

HRID 1520452 reaction equation
C([N:4]([CH:7]([CH3:9])C)[CH2:5]C)(C)C.CS(O[CH2:15][C:16]1[CH:21]=[CH:20][C:19]([C:22]2[CH:27]=[CH:26][C:25]([C@H:28]3[O:32]C(C)(C)[N:30]([C:35](=[O:39])[CH:36]([Cl:38])[Cl:37])[C@@H:29]3[CH2:40][F:41])=[CH:24][CH:23]=2)=[CH:18][N:17]=1)(=O)=O.N1CCC1.Cl>CN(C)C=O>[N:4]1([CH2:15][C:16]2[N:17]=[CH:18][C:19]([C:22]3[CH:23]=[CH:24][C:25]([C@@H:28]([OH:32])[C@H:29]([NH:30][C:35](=[O:39])[CH:36]([Cl:38])[Cl:37])[CH2:40][F:41])=[CH:26][CH:27]=3)=[CH:20][CH:21]=2)[CH2:5][CH2:9][CH2:7]1

Participants

6

Conditions

Temperature
0 °C

Procedure

Diisopropylethylamine (296 μL, 1.68 mmol) is added to the product of Example 20, Step 2 (50 mg, 0.11 mmol) and azetidine.HCl salt (146 mg, 1.12 mmol) in dimethylformamide (1 mL) and the mixture heated to 60° C. for 4 hours. The solvent is removed under reduced pressure and the residue dissolved in CH2Cl2 (2 mL). The mixture is cooled to 0° C. and trifluoroacetic acid (2 mL) added. After 1 hour, the solvent is removed under reduced pressure and the crude product purified using reverse phase HPLC to give the title compound (10 mg): m/z (Cl) M−H 425.1.

Workup

  1. customThe solvent is removed under reduced pressure
  2. dissolutionthe residue dissolved in CH2Cl2 (2 mL)
  3. additiontrifluoroacetic acid (2 mL) added
  4. customthe solvent is removed under reduced pressure
  5. customthe crude product purified

Sources & evidence

ORD record
ord-2733cb5402854973a407cfb208d6697a
Source dataset
uspto-grants-2015_07
Patent number
US09073894B2

Reaction notes

Loading…